1-(2-Aminoethyl)pyrrolidine

We are 1-(2-Aminoethyl)pyrrolidine CAS:7154-73-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  1-(2-Aminoethyl)pyrrolidine
CAS.NO:7154-73-6
Molecular Formula:C6H14N2
Molecular Weight:114.18900

Synonyms:
1-Pyrrolidineethanamine
2-pyrrolidin-1-ylethanamine

Physical and Chemical Properties:
Density: 0.901 g / mL at 25 ° C (lit.)
Boiling point: 66-70 ° C23 mm Hg (lit.)
Flash point: 118 ° F
Refractive index: n20 / D 1.468 (lit.)

Specification:
Appearance:Clear colorless to light brown  Liquid
Purity:≥99.0%
Moisture Content: 0.25%
Impurity: 0.3%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:An important raw material and intermediate used in Organic Synthesis,Pharmaceuticals.

Related News: The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself.2-amino-5-nitro-4-picolina CAS:21901-40-6 The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself.Ácido [9- (2-naftalenil) -9H-carbazol-3-il] borónico CAS:1133057-98-3 Due to the cyclic nature of the upstream chemical products of the API, it is expected that the impact of price fluctuations of raw materials on the performance of API companies is unavoidable, but companies with thick product lines and the ability to produce intermediates are expected to minimize the upstream price impact.2-bromo-4'-metilacetofenona CAS:619-41-0 Due to the cyclic nature of the upstream chemical products of the API, it is expected that the impact of price fluctuations of raw materials on the performance of API companies is unavoidable, but companies with thick product lines and the ability to produce intermediates are expected to minimize the upstream price impact.Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday.